Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.

Hello, and welcome to the second quarter fiscal Year 2025 Cardinal Health, Inc. earnings conference call. My name is George, and I'll be coordinator for today's event. Please note, this conference ...

Average Diluted Shares Outstanding: 243 million, 1% lower than a year ago. Cardinal Health Inc (NYSE:CAH) reported strong second quarter results, driven by robust demand in pharmaceutical and ...

The put/call ratio of CAH is 0.83 ... its portfolio allocation in CAH by 9.75% over the last quarter. Cardinal Health Background Information (This description is provided by the company.) ...

Cardinal Health exceeded EPS and revenue forecasts for Q2 2024. The stock fell by 1.61% in pre-market trading despite strong earnings. The company raised its full-year EPS guidance to $7.85-$8.00.

Cardinal Health CEO Jason Hollar recounted the company's "nice run" at the nation's largest annual healthcare industry conference. Cardinal Health Inc. raised its earnings outlook for fiscal 2025 ...

Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is ...

Hello, and welcome to the second quarter fiscal Year 2025 Cardinal Health, Inc. earnings conference call. My name is George, and I'll be coordinator for today's event. Please note, this conference is ...